IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

about

Emerging Roles of IL-33/ST2 Axis in Renal Diseases.The expression of RNA-binding protein RBM38 decreased in renal cell carcinoma and represses renal cancer cell proliferation, migration, and invasion.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

P2860

Q39226501-B5AFCC2E-BE05-4E91-B584-84F60F73ABCF Q50687498-394DD3BE-F7DA-4942-87AB-7D7FC8EF6794 Q58707724-F809B2B1-CE41-4B91-A24D-E77CFE75F5C7

P2860

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q40881169

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

IL-33 is associated with unfav ...... ear-cell renal cell carcinoma.

@en

type

Item

label

IL-33 is associated with unfav ...... ear-cell renal cell carcinoma.

@en

prefLabel

IL-33 is associated with unfav ...... ear-cell renal cell carcinoma.

@en

P1476

IL-33 is associated with unfav ...... ear-cell renal cell carcinoma.

@en

P2093

Hangcheng Fu

http://www.w3.org/2001/XMLSchema#string

Jiejie Xu

http://www.w3.org/2001/XMLSchema#string

Le Xu

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Weijuan Zhang

http://www.w3.org/2001/XMLSchema#string

Yuan Chang

http://www.w3.org/2001/XMLSchema#string

Yuanfeng Yang

http://www.w3.org/2001/XMLSchema#string

Zewei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Nuclear factor-kappaB in cancer development and progression

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages.

The epidemiology of renal cell carcinoma.

Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

P2888

s13277-016-4879-3

P304

11127-11134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-4879-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006452281

http://www.w3.org/2001/XMLSchema#string

P698

26926076

http://www.w3.org/2001/XMLSchema#string

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

about

P2860

P2860

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698